Physician profile
John Eric Fleming
NPI 1235511601
$941.49
in general payments reported to CMS, 2019-2025
19 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.71 · 2020: $110 · 2021: $64.57 · 2022: $173 · 2023: $315 · 2024: $82.63 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $162.55 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $151.45 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $108.85 | 2019-2022 | |
| Dexcom, INC. | $89.26 | 2023-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $50.02 | 2021-2023 | Farxiga |
| Amgen INC. | $49.29 | 2023-2025 | Repatha, Prolia, Evenity |
| Abbvie INC. | $45.05 | 2023 | |
| Novartis Pharmaceuticals Corporation | $41.85 | 2019-2022 | |
| Philips North America LLC | $35.88 | 2021-2024 | (Ck7) Extended Holter |
| Allergan, INC. | $35.22 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.88 | 2020-2021 | |
| Exact Sciences Corporation | $28.77 | 2023 | Cologuard Collection Kit |
| Tandem Diabetes Care, INC. | $21.05 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Advanced Respiratory, INC | $18.78 | 2019 | |
| Csl Behring | $17.55 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.26 | 2025 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $14.23 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.19 | 2023 | Quviviq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.